Sharyn N. Lewin, MD, discusses the importance of screening patients with ovarian cancer for a BRCA mutation.
5-Year CAPTIVATE Results Show Promise in CLL/SLL With Ibrutinib/Venetoclax
In an interview with Targeted Oncology, Paolo Ghia, MD, PhD, discussed the 5-year results from the CAPTIVATE study in chronic lymphocytic leukemia and/or small lymphocytic lymphoma.
Read More
The Future of Breast Cancer Care: Blackwood on Personalized Approaches
In this episode of Targeted Talks, M. Michele Blackwood, MD, FACS, discusses the current landscape of breast cancer treatment and how personalized medicine with genomic testing is changing the field.
Listen
Avutometinib/Defactinib Seeks FDA Approval for Ovarian Cancer via Rolling NDA
A rolling new drug application is being submitted to the FDA for an ovarian cancer treatment combination of avutometinib and defactinib.
Advancing the Treatment of Cervical and Endometrial Cancers
In season 2, episode 6 of Targeted Talks, Alexander B. Olawaiye, MD leads a discussion with Haider S. Mahdi, MD, about the modern approaches to treating cervical and endometrial cancers.
Higher Rates of Nephrectomy in Patients With RCC With Prior Thymectomy
In an interview with Targeted Oncology, Regina Barragan-Carrillo, MD, discussed the background and findings from a study comparing patients who underwent thymectomy and nephrectomy.
Estrogen Therapy Alone Raises Ovarian/Endometrial Cancer Risk in Postmenopausal Women After Hysterectomy
CEE therapy alone in postmenopausal women after hysterectomy was linked to a substantial increase in ovarian cancer incidence and mortality.